Ikarian Capital, LLC Cyma Bay Therapeutics, Inc. Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$10.86 - $17.62 $1.13 Million - $1.84 Million	104,300 New	104,300 $1.56 Million
Q3 2020 Nov 16, 2020	SELL	$3.32 - $7.24 $5.08 Million - $11.1 Million	-1,529,830 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.41 - $4.25 $1.18 Million - $3.56 Million	-837,020 Reduced 35.36%	1,529,830 $5.34 Million
Q1 2020 May 15, 2020	BUY	$1.25 - $2.02 $2.96 Million - $4.78 Million	2,366,850 New	2,366,850 $3.5 Million

1.88M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.